Is There Light at the End of the Thin-Strut Tunnel?: In Vitro Insights on Strut Thickness Impact on Thrombogenicity in Bioresorbable Stents or Scaffolds

JACC Cardiovasc Interv. 2018 Apr 9;11(7):714-716. doi: 10.1016/j.jcin.2018.01.237.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Absorbable Implants / adverse effects*
  • Animals
  • Blood Coagulation
  • Cardiovascular Agents / toxicity
  • Coronary Circulation
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / diagnostic imaging
  • Coronary Thrombosis / etiology*
  • Coronary Thrombosis / physiopathology
  • Drug-Eluting Stents / adverse effects*
  • Everolimus / toxicity
  • Hemodynamics
  • Materials Testing
  • Models, Anatomic
  • Models, Cardiovascular
  • Percutaneous Coronary Intervention / adverse effects*
  • Percutaneous Coronary Intervention / instrumentation*
  • Platelet Activation
  • Prosthesis Design*
  • Risk Assessment
  • Risk Factors
  • Sus scrofa
  • Tomography, Optical Coherence

Substances

  • Cardiovascular Agents
  • Everolimus